Compare PLOW & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLOW | XERS |
|---|---|---|
| Founded | 1948 | 2005 |
| Country | United States | United States |
| Employees | 1764 | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2010 | 2021 |
| Metric | PLOW | XERS |
|---|---|---|
| Price | $44.31 | $6.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $51.50 | $10.83 |
| AVG Volume (30 Days) | 256.5K | ★ 1.6M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | N/A | ★ 100.00 |
| EPS | ★ 0.26 | 0.01 |
| Revenue | ★ $656,053,000.00 | $49,590,000.00 |
| Revenue This Year | $13.71 | $34.37 |
| Revenue Next Year | $5.36 | $22.86 |
| P/E Ratio | ★ $166.96 | $638.48 |
| Revenue Growth | 15.40 | ★ 142.67 |
| 52 Week Low | $27.13 | $4.30 |
| 52 Week High | $52.33 | $10.08 |
| Indicator | PLOW | XERS |
|---|---|---|
| Relative Strength Index (RSI) | 48.29 | 49.57 |
| Support Level | $40.95 | $5.79 |
| Resistance Level | $47.58 | $6.41 |
| Average True Range (ATR) | 2.01 | 0.32 |
| MACD | -0.28 | -0.02 |
| Stochastic Oscillator | 20.87 | 28.51 |
Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.